These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2132641)

  • 1. Topographic mapping of cognitive event-related potentials in a double-blind, placebo-controlled study with the hemoderivative Actovegin in age-associated memory impairment.
    Semlitsch HV; Anderer P; Saletu B; Hochmayer I
    Neuropsychobiology; 1990-1991; 24(1):49-56. PubMed ID: 2132641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EEG brain mapping and psychometry in age-associated memory impairment after acute and 2-week infusions with the hemoderivative Actovegin: double-blind, placebo-controlled trials.
    Saletu B; Grünberger J; Linzmayer L; Anderer P; Semlitsch HV
    Neuropsychobiology; 1990-1991; 24(3):135-48. PubMed ID: 2135068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrical sources of P300 event-related brain potentials revealed by low resolution electromagnetic tomography. 2. Effects of nootropic therapy in age-associated memory impairment.
    Anderer P; Saletu B; Semlitsch HV; Pascual-Marqui RD
    Neuropsychobiology; 1998; 37(1):28-35. PubMed ID: 9438269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Functional improvement of the aging brain: placebo controlled pharmaco-EEG and psychometric studies with a metabolically active hemoderivative (Actovegin)].
    Saletu B; Grünberger J; Linzmayer L; Stöhr H
    Z Gerontol; 1984; 17(5):271-9. PubMed ID: 6395527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive psychophysiology in nootropic drug research: effects of Ginkgo biloba on event-related potentials (P300) in age-associated memory impairment.
    Semlitsch HV; Anderer P; Saletu B; Binder GA; Decker KA
    Pharmacopsychiatry; 1995 Jul; 28(4):134-42. PubMed ID: 7491367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychophysiological research in psychiatry and neuropsychopharmacology. II. The investigation of antihypoxidotic/nootropic drugs (tenilsetam and co-dergocrine-mesylate) in elderlies with the Viennese Psychophysiological Test-System (VPTS).
    Saletu B; Semlitsch HV; Anderer P; Resch F; Presslich O; Schuster P
    Methods Find Exp Clin Pharmacol; 1989 Jan; 11(1):43-55. PubMed ID: 2716439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ARTEMIDA Trial (A Randomized Trial of Efficacy, 12 Months International Double-Blind Actovegin): A Randomized Controlled Trial to Assess the Efficacy of Actovegin in Poststroke Cognitive Impairment.
    Guekht A; Skoog I; Edmundson S; Zakharov V; Korczyn AD
    Stroke; 2017 May; 48(5):1262-1270. PubMed ID: 28432265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topographic mapping of long latency "cognitive" event-related potentials (P 300): a double-blind, placebo-controlled study with amantadine in mild dementia.
    Semlitsch HV; Anderer P; Saletu B
    J Neural Transm Park Dis Dement Sect; 1992; 4():319-36. PubMed ID: 1388702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perceptual and cognitive event-related potentials in neuropsychopharmacology: methodological aspects and clinical applications (pharmaco-ERP topography and tomography).
    Anderer P; Saletu B; Semlitsch HV; Pascual-Marqui RD
    Methods Find Exp Clin Pharmacol; 2002; 24 Suppl C():121-37. PubMed ID: 12575494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute effects of the anxiolytics suriclone and alprazolam on cognitive information processing utilizing topographic mapping of event-related brain potentials (P300) in healthy subjects.
    Semlitsch HV; Anderer P; Saletu B
    Eur J Clin Pharmacol; 1995; 49(3):183-91. PubMed ID: 8665994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain regions activated during an auditory discrimination task in insomniac postmenopausal patients before and after hormone replacement therapy: low-resolution brain electromagnetic tomography applied to event-related potentials.
    Anderer P; Saletu B; Saletu-Zyhlarz G; Gruber D; Metka M; Huber J; Pascual-Marqui RD
    Neuropsychobiology; 2004; 49(3):134-53. PubMed ID: 15034229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modafinil improves information processing speed and increases energetic resources for orientation of attention in narcoleptics: double-blind, placebo-controlled ERP studies with low-resolution brain electromagnetic tomography (LORETA).
    Saletu M; Anderer P; Saletu-Zyhlarz GM; Mandl M; Saletu B; Zeitlhofer J
    Sleep Med; 2009 Sep; 10(8):850-8. PubMed ID: 19342295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind, placebo-controlled, multiple-ascending-dose study on the effects of ABIO-08/01, a novel anxiolytic drug, on perception and cognition, utilizing event-related potential mapping and low-resolution brain electromagnetic tomography.
    Anderer P; Saletu B; Wolzt M; Culic S; Assandri A; Nannipieri F; Rosini S; Saletu-Zyhlarz GM
    Hum Psychopharmacol; 2008 Apr; 23(3):243-54. PubMed ID: 18181252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiological neuroimaging of the central effects of S-adenosyl-L-methionine by mapping of electroencephalograms and event-related potentials and low-resolution brain electromagnetic tomography.
    Saletu B; Anderer P; Di Padova C; Assandri A; Saletu-Zyhlarz GM
    Am J Clin Nutr; 2002 Nov; 76(5):1162S-71S. PubMed ID: 12418497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic transdermal nicotine patch treatment effects on cognitive performance in age-associated memory impairment.
    White HK; Levin ED
    Psychopharmacology (Berl); 2004 Feb; 171(4):465-71. PubMed ID: 14534771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multilead quantitative electroencephalogram profile and cognitive evoked potentials (P300) in healthy subjects after a single dose of olanzapine.
    Hubl D; Kleinlogel H; Frölich L; Weinandi T; Maurer K; Holstein W; Czekalla J; Dierks T
    Psychopharmacology (Berl); 2001 Nov; 158(3):281-8. PubMed ID: 11713618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of education level on design-induced N170 and P300 components of event related potentials in the human brain.
    Begum T; Reza F; Ahmed I; Abdullah JM
    J Integr Neurosci; 2014 Mar; 13(1):71-88. PubMed ID: 24738540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind placebo-controlled, neuropsychological and neurophysiological investigations with oxiracetam (CGP 21690E) in memory-impaired patients with epilepsy.
    Aldenkamp AP; van Wieringen A; Alpherts WC; van Emde Boas W; Haverkort HA; de Vries J; Meinardi H
    Neuropsychobiology; 1990-1991; 24(2):90-101. PubMed ID: 2134116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of actovegin in the treatment of elderly patients with vascular mild cognitive impairment].
    Mikhaĭlova NM; Selezneva ND; Kalyn IaB; Roshchina IF; Gavrilova SI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(7 Pt 2):69-76. PubMed ID: 23994934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a cholinergic nootropic (WEB 1881 FU) on event-related potentials recorded in incidental and intentional memory tasks.
    Münte TF; Heinze HJ; Scholz M; Künkel H
    Neuropsychobiology; 1988; 19(3):158-68. PubMed ID: 3059222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.